Treatment with recombinant human growth hormone (r-hGH) is indicated in a range of short stature pathologies [3, 4] including growth hormone deficiency, Turner syndrome, chronic renal impairment, Prader-Willi syndrome, Noonan syndrome, ISS and the child born SGA. Here, GH1 is linked to Prader-Willi syndrome.